Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies

References

• Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10:1616–1622
   PubMed Web of Science ®Google Scholar
• Moore MJ, Flink EB. Magnesium deficiency as a cause of serious arrhythmias. Arch Intern Med. 1978;138:825–826
   PubMedGoogle Scholar
• Vallee BL, Wacker WE, Ulmer DD. The magnesium-deficiency tetany syndrome in man. N Engl J Med. 1960;262:155–161
   PubMed Web of Science ®Google Scholar
• Flink EB. Magnesium deficiency. Etiology and clinical spectrum. Acta Med Scand Suppl. 1981;647:125–137
   PubMedGoogle Scholar
• Danziger J, William JH, Scott DJ, et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83:692–699
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85:174–181
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Ittermann T, Dorr M, et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011;219:280–284
   PubMed Web of Science ®Google Scholar
• Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol. 2008;19:50–56
   PubMed Web of Science ®Google Scholar
• Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The atherosclerosis risk in communities (Aric) study. Am Heart J. 1998;136:480–490
   PubMed Web of Science ®Google Scholar
• Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: A systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98:160–173
   PubMed Web of Science ®Google Scholar
• Alves SC, Tomasi CD, Constantino L, et al. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2013;28:910–916
   PubMed Web of Science ®Google Scholar
• Sierra F, Suarez M, Rey M, Vela MF. Systematic review: Proton pump inhibitor-associated acute interstitial nephritis. Aliment Pharmacol Ther. 2007;26:545–553
   PubMed Web of Science ®Google Scholar
• Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection. Arch Intern Med. 2010;170:784–790
   PubMed Web of Science ®Google Scholar
• Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301:2120–2128
   PubMed Web of Science ®Google Scholar
• Yu EW, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: A meta-analysis of 11 international studies. Am J Med. 2011;124:519–526
   PubMed Web of Science ®Google Scholar
• Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: Hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012;36:405–413
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services F DSC. Drug safety communication—Low magnesium levels can be associated with long-term use. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm. Accessed March 3, 2011
   Google Scholar
• Gau JT, Yang YX, Chen R, Kao TC. Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf. 2012;21:553–559
   PubMed Web of Science ®Google Scholar
• Kim S, Lee H, Park CH, et al. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. Am J Ther. 2015;22:14--21
   PubMed Web of Science ®Google Scholar
• Markovits N, Loebstein R, Halkin H, et al. The association of proton pump inhibitors and hypomagnesemia in the community setting. J Clin Pharmacol. 2014;54:889–895
   PubMed Web of Science ®Google Scholar
• Smith K, Gatesman ML, Harpe SE, Clark W. Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving h-2 receptor antagonists or proton pump inhibitors. Bone Marrow Transplant. 2014;49:1106–1108
   PubMed Web of Science ®Google Scholar
• El-Charabaty E, Saifan C, Abdallah M, et al. Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias. Int J Gen Med. 2013;6:515–518
   PubMedGoogle Scholar
• Gil HW PS, Hong SY. Change in serum magnesium concentration after use of a proton pump inhibitor. 51st ERA-EDTA Congress, Amsterdam, Netherlands: Oxford University Press; 2014;29:iii180–iii181
   Google Scholar
• Koulouridis I, Alfayez M, Tighiouart H, et al. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: A nested case-control study. Am J Kidney Dis. 2013;62:730–737
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
   PubMed Web of Science ®Google Scholar
• Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867–872
   PubMed Web of Science ®Google Scholar
• Faulhaber GA, Ascoli BM, Lubini A, et al. Serum magnesium and proton-pump inhibitors use: A cross-sectional study. Rev Assoc Med Bras. 2013;59:276–279
   PubMed Web of Science ®Google Scholar
• Perazella MA. Proton pump inhibitors and hypomagnesemia. A rare but serious complication. Kidney Int. 2013;83:553–556
   PubMed Web of Science ®Google Scholar